Andy King
Head of Trials Programming
Andy is responsible for the IT management of the National Perinatal Epidemiology Unit (NPEU) Clinical Trial Unit's (CTU) work, including the computing aspects of the design and conduct of NPEU CTU randomised controlled trials, and has particular responsibility for the randomisation systems.
Since joining the NPEU in 1996, he has worked on numerous projects (including 4Child and UKCP) and clinical trials (including the Hip Trial, INIS, BOOST-II UK, I2S2, PiPS, Poppi and Baby-OSCAR).
After graduating from the University of Oxford with a BA in Mathematics, Andy was self-employed as a computer programmer working for several Oxford colleges and the NHS. In 2009, he became Senior Trials Programmer, and in 2014 was appointed Head of Trials Programming.
Key publications
Parent and practitioner experiences of opt-out consent in neonatal intensive care: a mixed methods study within a trial.
Journal article
Mitchell T. et al, (2026), Arch Dis Child Fetal Neonatal Ed, 111, F162 - F168
Recent publications
Parent and practitioner experiences of opt-out consent in neonatal intensive care: a mixed methods study within a trial.
Journal article
Mitchell T. et al, (2026), Arch Dis Child Fetal Neonatal Ed, 111, F162 - F168
Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial (Baby-OSCAR trial).
Journal article
Gupta S. et al, (2026), Health Technol Assess, 30, 1 - 17
Trial protocol: DOLFIN trial: Developmental Outcomes of Long-term Feed Supplementation in Neonates-A UK multicentre, blinded, stratified, randomised controlled trial.
Journal article
Andrew MJ. et al, (2025), Trials, 26
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group ., (2025), EClinicalMedicine, 81